Cargando…
κ-opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca(2+)/CaMKII/CREB signaling pathway and improves synaptic plasticity in APP/PS1 mice
Alzheimer's disease (AD) is a progressive neurodegenerative brain disorder with slow onset in most cases. Clinically, dementia associated with AD is characterized by memory disorders, aphasia, executive dysfunction and personality and behavior changes. Currently, treatment strategies attempt to...
Autores principales: | Song, Xiaofu, Cui, Zhiqiang, He, Jiahuan, Yang, Tuo, Sun, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170177/ https://www.ncbi.nlm.nih.gov/pubmed/34036389 http://dx.doi.org/10.3892/mmr.2021.12168 |
Ejemplares similares
-
The κ-Opioid Receptor Agonist U50488H Ameliorates Neuropathic Pain Through the Ca(2+)/CaMKII/CREB Pathway in Rats
por: Zhang, Xiao-Min, et al.
Publicado: (2022) -
Synaptic memory and CaMKII
por: Nicoll, Roger A., et al.
Publicado: (2023) -
Synaptic memory requires CaMKII
por: Tao, Wucheng, et al.
Publicado: (2021) -
κ-Opioid Receptor Agonist Ameliorates Postoperative Neurocognitive Disorder by Activating the Ca(2+)/CaMKII/CREB Pathway
por: Ding, Guopeng, et al.
Publicado: (2021) -
Retracted: κ-Opioid Receptor Agonist Ameliorates Postoperative Neurocognitive Disorder by Activating the Ca(2+)/CaMKII/CREB Pathway
por: Healthcare Engineering, Journal of
Publicado: (2022)